Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Top Cited Papers
- 1 October 2014
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 66 (4), 704-710
- https://doi.org/10.1016/j.eururo.2014.05.034
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mortality and Morbidity After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Population-Based StudyAnnals of Surgical Oncology, 2011
- The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted TherapyJournal of Urology, 2011
- Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell CarcinomaEuropean Urology, 2011
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2009
- Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell CarcinomaThe New England Journal of Medicine, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaThe New England Journal of Medicine, 2007
- Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinomaAnnals of Oncology, 2006
- Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2005
- Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined AnalysisJournal of Urology, 2004